Proteins and Peptides

14 Dec 2007 Shire expands its gastrointestinal portfolio through in-licensing Celiac disease Phase 2 product from Alba Therapeutics Corporation
13 Dec 2007 Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
13 Dec 2007 Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
12 Dec 2007 Final phase 3 study confirms very favourable effect of liraglutide on blood glucose control and body weight
11 Dec 2007 ZymoGenetics Presents PEG-Interferon Lambda Phase 1a Data
11 Dec 2007 Medicis and Revance Announce Strategic Collaboration
10 Dec 2007 ZymoGenetics Presents Positive Interim Phase 1 Results for IL-21 in Combination with Rituxan(R) in B Cell Lymphoma
10 Dec 2007 CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
10 Dec 2007 Gloucester Pharmaceuticals Reports Clinically Significant Responses in Pivotal Trial of Romidepsin for Cutaneous T-cell Lymphoma at the 2007 American Society of Hematology (ASH) Annual Meeting
09 Dec 2007 Nuvelo Phase 3 SONOMA-2 Trial Shows Alfimeprase has the Potential to Restore Catheter Function
08 Dec 2007 Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
07 Dec 2007 Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
07 Dec 2007 Submission of Marketing Authorisation Application for Dapoxetine in Europe
07 Dec 2007 Access Pharmaceuticals Demonstrates Ability To Significantly Reduce Glucose Levels in Pre-clinical Testing of
06 Dec 2007 Ipsen submits a Biologics License Application (BLA) in cervical dystonia to the FDA for Dysport(R)
06 Dec 2007 Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA
05 Dec 2007 Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
05 Dec 2007 GTC Biotherapeutics Obtains Licenses to Factor IX, Factor VIII and Fibrinogen
04 Dec 2007 ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
04 Dec 2007 Early Treatment with COPAXONE® Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
03 Dec 2007 Fibrex Medical Completes Enrolment of Phase II Trial of Treatment for
03 Dec 2007 Clal Biotechnology Industries and Teva Pharmaceuticals Solidify their Collaboration for Final Stage Development of Type 1 Diabetes Drug
03 Dec 2007 BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
03 Dec 2007 Buck Institute and Neurobiological Technologies, Inc. Partner to Develop Treatment for Huntington's Disease
30 Nov 2007 Amgen Announces Interim Results of Aranesp(R) ''PREPARE'' Study in Breast Cancer Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top